Technical Analysis for ALPN - Alpine Immune Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 38.12% | |
MACD Bullish Signal Line Cross | Bullish | 38.12% | |
New 52 Week Closing High | Bullish | 38.12% | |
Expansion Breakout | Bullish Swing Setup | 38.12% | |
Pocket Pivot | Bullish Swing Setup | 38.12% | |
Reversal New Highs Setup | Bullish Swing Setup | 38.12% | |
Volume Surge | Other | 38.12% | |
Wide Range Bar | Range Expansion | 38.12% | |
New 52 Week High | Strength | 38.12% | |
20 DMA Support | Bullish | 66.85% |
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Alpine Immune Sciences, Inc., a development-stage specialty pharmaceutical company, engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. It is developing ALPN-101, an ICOS/CD28 antagonist program for the treatment of inflammatory diseases. The company is based in Seattle, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 64.97 |
52 Week Low | 8.33 |
Average Volume | 2,648,236 |
200-Day Moving Average | 25.76 |
50-Day Moving Average | 51.40 |
20-Day Moving Average | 64.68 |
10-Day Moving Average | 64.78 |
Average True Range | 0.80 |
RSI (14) | 83.42 |
ADX | 64.18 |
+DI | 52.32 |
-DI | 9.16 |
Chandelier Exit (Long, 3 ATRs) | 62.58 |
Chandelier Exit (Short, 3 ATRs) | 66.79 |
Upper Bollinger Bands | 64.99 |
Lower Bollinger Band | 64.36 |
Percent B (%b) | 0.97 |
BandWidth | 0.97 |
MACD Line | 3.65 |
MACD Signal Line | 4.63 |
MACD Histogram | -0.9822 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 65.02 | ||||
Resistance 3 (R3) | 65.01 | 64.99 | 65.01 | ||
Resistance 2 (R2) | 64.99 | 64.98 | 64.99 | 65.00 | |
Resistance 1 (R1) | 64.98 | 64.97 | 64.99 | 64.99 | 65.00 |
Pivot Point | 64.96 | 64.96 | 64.96 | 64.96 | 64.96 |
Support 1 (S1) | 64.95 | 64.95 | 64.96 | 64.96 | 64.94 |
Support 2 (S2) | 64.93 | 64.94 | 64.93 | 64.94 | |
Support 3 (S3) | 64.92 | 64.93 | 64.93 | ||
Support 4 (S4) | 64.93 |